ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Takeda Pharmaceutical U.s.a., INC.

Official 2024 U.S. DOL Form 5500 summary for Takeda Pharmaceutical U.s.a., INC. (Takeda Pharmaceutical U.s.a., INC. Savings And Retirement Plan · EIN 13-4013710 · PN 001): $6.18B net assets, 23,331 active participants, and $5.10 per $10,000 (5.10 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorTakeda Pharmaceutical U.s.a., INC.
Filing IdentifierTakeda Pharmaceutical U.s.a., INC. Savings And Retirement Plan · EIN 13-4013710 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort>$1B
Plan Net Assets (2024)$6.18B
Active Participants23,331
Direct Admin Fee Rate$5.10 per $10,000 (5.10 bps)
Cohort Peer Median$4.40 per $10,000 (4.40 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI

Cross-Agency Entity Graph

Related Filings Across Meru Platforms

Verified federal filings reconciled for Takeda across sibling Meru AI platforms.